Lexicon is a Texas-based biopharmaceutical company that discovers and develops gene therapy medicines for the treatment of chronic diseases...
Read moreLexicon is a Texas-based biopharmaceutical company that discovers and develops gene therapy medicines for the treatment of chronic diseases...
Read moreAnnual Revenue
$ < 1M
Lexicon's revenue is the ranked 27th among it's top 10 competitors. The top 10 competitors average 5.7B. Over the last four quarters, Lexicon's revenue has grown by 69.6%. Specifically, in Q3 2022's revenue was $ < 1M; in Q2 2022, it was $ < 1M; in Q1 2022, it was $ < 1M; in Q3 2021, Lexicon's revenue was $ < 1M.